The role of Cyclin Dependent Kinase Inhibitor 3 (CDKN3) in promoting human tumors: Literature review and pan-cancer analysis
Background: Although many experiments and clinical studies have proved the link between the expression of CDKN3 and human tumors, we have not been able to identify any bioinformatics study in which the extensive tumor-promoting effect of CDKN3 was systematically analyzed. Objective: Explore the exte...
Main Authors: | Chuanlong Zhang, Qian Shen, Mengqi Gao, Junchen Li, Bo Pang |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2024-02-01
|
Series: | Heliyon |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2405844024020929 |
Similar Items
-
Expression of cyclin-dependent kinase inhibitors (CDKN1, CDKN5) in developmentally competent and incompetent porcine oocytes
by: H. Piotrowska, et al.
Published: (2013-09-01) -
A pan-cancer analysis for the oncogenic role of cyclin-dependent kinase inhibitor 1B in human cancers
by: Hao Huang, et al.
Published: (2023-07-01) -
Discovering the mechanism and involvement of the methylation of cyclin-dependent kinase inhibitor 2A (CDKN2A) gene and its special locus region in gastric cancer
by: Jiye Xu, et al.
Published: (2021-01-01) -
HMMR potential as a diagnostic and prognostic biomarker of cancer—speculation based on a pan-cancer analysis
by: Junyi Shang, et al.
Published: (2023-01-01) -
Prognostic significance of the rho GTPase RHOV and its role in tumor immune cell infiltration: a comprehensive pan‐cancer analysis
by: Qin Qin, et al.
Published: (2023-11-01)